Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

Background. Early diagnosis and treatment are crucial in invasive fungal diseases (IFD). Serum (1-3)-β-d-glucan (BG) is believed to be an early IFD marker, but its diagnostic performance has been ambiguous, with insufficient data regarding sensitivity at the time of IFD diagnosis (TOD) and according...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Open Forum Infect Dis
मुख्य लेखकों: Angebault, Cécile, Lanternier, Fanny, Dalle, Frédéric, Schrimpf, Cécile, Roupie, Anne-Laure, Dupuis, Aurélie, Agathine, Aurélie, Scemla, Anne, Paubelle, Etienne, Caillot, Denis, Neven, Bénédicte, Frange, Pierre, Suarez, Felipe, d'Enfert, Christophe, Lortholary, Olivier, Bougnoux, Marie-Elisabeth
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2016
विषय:
Major Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942764/
https://ncbi.nlm.nih.gov/pubmed/27419189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw128
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन